Antibody Titration in Hemolytic Disease of the Fetus and Newborn - State of the Art

被引：0
|
作者：
Flommersfeld, Sabine [1 ]
Ertl, Birgit [1 ]
机构：
[1] Univ Klinikum Giessen & Marburg, Zentrum Transfus Med & Hamotherapie, Baldingerstr, D-35043 Marburg, Germany
来源：
TRANSFUSIONSMEDIZIN | 2018年 / 8卷 / 02期
关键词：
alloimmunization; antibody titration; hemolytic disease of the newborn;
D O I：
10.1055/s-0043-121113
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Immunohematological results may not correlate with the clinical outcome of patients. Especially in fetomaternal incompatibility it would be desirable to have a validated method for prediction of the clinical relevance of an antibody. Antibody titration is widely used. Quality controls are not standardized and methods and interpretation of results differ. A reliable method for antibody titration is described and its pro's and con's will be discussed.
引用
收藏
页码：90 / 94
页数：5
相关论文
共 50 条
  • [31] Hemolytic disease of the fetus and newborn due to multiple maternal antibodies
    Markham, Kara Beth
    Rossi, Karen Q.
    Nagaraja, Haikady N.
    O'Shaughnessy, Richard W.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2015, 213 (01) : 68.e1 - 68.e5
  • [32] DURATION OF HEMOLYSIS AMONG INFANTS WITH HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN
    Bahr, T. M.
    Moise, K.
    Lowry, K.
    Monson, M.
    Hammad, I
    Goteti, S.
    Ilstrup, S. J.
    Vanasco, P.
    Ohls, R. K.
    Christensen, R. D.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 527 - 528
  • [33] Hemolytic Disease of the Fetus and Newborn: Modern Practice and Future Investigations
    Hendrickson, Jeanne E.
    Delaney, Meghan
    TRANSFUSION MEDICINE REVIEWS, 2016, 30 (04) : 159 - 164
  • [34] Hemolytic disease of the fetus and newborn due to multiple alloantibodies in pregnancy
    Gupta, Vidushi
    Sidhu, Meena
    Shah, Saadat Nazir
    ASIAN JOURNAL OF TRANSFUSION SCIENCE, 2020, 14 (01) : 83 - 86
  • [35] Janssen’s nipocalimab tackles hemolytic disease of the fetus and newborn
    Thiago Carvalho
    Nature Medicine, 2023, 29 : 757 - 758
  • [36] Fatal hemolytic disease of the fetus and newborn caused by anti-Jra antibody: A case report and literature review
    Kim, Min-Sun
    Kim, Jin Seok
    Park, Hyewon
    Chung, Yousun
    Kim, Hyungsuk
    Ko, Dae-Hyun
    Hwang, Sang-Hyun
    Won, Hye-Sung
    Oh, Heung-Bum
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (01)
  • [37] Hemolytic Disease of the Fetus and Newborn Part 2: Diagnosis and Treatment of hemolytic Disease of the Newborns, Primary Prophylaxis
    Axt-Fliedner, Roland
    Wienzek-Lischka, Sandra
    Sachs, Ulrich J.
    Cooper, Nina
    Zimmer, Klaus-Peter
    Ehrhardt, Harald
    Bein, Gregor
    TRANSFUSIONSMEDIZIN, 2018, 8 (02) : 111 - 118
  • [38] Absence of hemolytic disease of fetus and newborn (HDFN) in a pregnancy with anti-Yka (York) red cell antibody
    Decaro, Jorge
    Pedrozo, Angel
    Gularte, Martin
    Tironi, Gustavo
    Citrin, Estela
    CASE REPORTS IN PERINATAL MEDICINE, 2012, 1 (1-2): : 29 - 31
  • [39] Dramatic increase of antibody titers and severe hemolytic disease of the fetus and newborn following an episode of mild vaginal bleeding
    Sohsman, M.
    Tabsh, K.
    Ziman, A.
    Yuan, S.
    Goldfinger, D.
    Lu, Q.
    TRANSFUSION, 2008, 48 (02) : 53A - 53A
  • [40] Hemolytic disease of the fetus and newborn: rapid review of postnatal care and outcomes
    de Winter, Derek P.
    Kaminski, Allysen
    Tjoa, May Lee
    Oepkes, Dick
    Lopriore, Enrico
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
12345